Final Study Report: Sources of Financing and Policy Recommendations on Boosting eHealth Investment

Sources of Financing and Policy Recommendations to Member States and the European Commission on Boosting eHealth InvestmentThe Financing eHealth study was commissioned by DG INFSO and Media's ICT for Health Unit. The aim is to assess different financing opportunities against the financing needs of eHealth investment. The overriding goal of the study, and of this final report, is to assist Member States and the European Commission (EC) in their efforts to meet the eHealth Action Plan objective of "supporting and boosting investment in eHealth".

A sobering conclusion of the study is that just increasing finance for eHealth will not necessarily boost investment. How much to spend is the wrong question and conveys an inappropriate perspective. What to spend the money spent on is a better question. The most important part of eHealth investment that needs expanding is the eHealth skills and knowledge of healthcare staff and ICT suppliers' staff. An expanded capability is essential to achieve more success and so help to boost eHealth investment.

Increased capability helps to secure the potential and confidence that eHealth will add enough value. If an investment is worth it, providing the required finance becomes a supporting priority. Denying finance for eHealth is the right decision where the planned investment does not show a better net benefit than other types of competing investment. Choosing the best financing arrangement is a challenge for eHealth investors. A common theme seems to be the difficulty in integrating eHealth financing into the factors that ensure success. Over-emphasising finance for ICT to the detriment of engagement, change, and benefits realisation may be prevalent, and needs correcting.

No single source of financing is enough to initiate an eHealth investment and see it through to its completion. Mixed financing arrangements are a solution to handle such investments at all stages of their lifecycle. This applies to both recurring and nonrecurring costs. Joint financing for recurring costs is a model in which all beneficiaries have to be involved in the financing stage. Current financing opportunities support a limited, and often insufficient, time-period of the investment lifecycle. Therefore a combination of sources is suitable to support an investment, and its characteristics determine the finance mix. Often, different models of eHealth financing need combining to procure such investments.

Download Sources of Financing and Policy Recommendations to Member States and the European Commission on Boosting eHealth Investment Final study report (.pdf, 847 KB).

Download from the eHealthNews.EU Portal's mirror: Sources of Financing and Policy Recommendations to Member States and the European Commission on Boosting eHealth Investment Final study report (.pdf, 847 KB).

For further information, please visit:
http://www.financing-ehealth.eu

Related news articles:

About empirica
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH (empirica) has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com.

About Financing eHealth study
The Financing eHealth study was commissioned by DG INFSO and Media, unit ICT for Health, with the aim to assess different financing opportunities against the financing needs of eHealth investment. The overriding goal is to provide assistance to Member States and the European Commission in their efforts to meet the eHealth Action Plan objective of "supporting and boosting investment in eHealth".

The study focuses on providing insights and specific recommendations on:

  • developing the supply side of eHealth finance to optimise the use of resources available for boosting investment in eHealth, including ways to add value through collaboration between Member States;
  • effective and efficient management of eHealth investment to support health services providers, i.e. the demand side.

These recommendations aim to help close the gap between supply of and demand for eHealth financing, and thus support Member States and the European Commission in their activities.

For further information, please visit http://www.financing-ehealth.eu.

Most Popular Now

Artificial Intelligence in Healthcare Re…

This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of...

New App Helps Parents Identify Treatable…

A ground-breaking new, mobile phone app, 'GrowthMonitor' places the accurate measurement of children's height in the hands of parents and carers. Preliminary data to be presented at the Society for...

Dedalus Acquires Swiftqueue to Support P…

Dedalus Group ("Dedalus"), a leading international healthcare software solutions provider, has announced to have completed the acquisition of 100% of Swiftqueue Technologies Ltd a fast-growing cloud-native appointment and scheduling solution...

Bittium Exhibits its High-Tech Medical T…

Bittium exhibits its innovative products and solutions for cardiology and neurophysiology as well as R&D services for the development of medical and healthcare technology at the MEDICA 2021 event. It...

Development of AI Technology for Produci…

Transcranial focused ultrasound can be used to treat degenerative movement disorders, intractable pain, and mental disorders by delivering ultrasound energy to a specific area of the brain without opening the...

FDA Authorizes Marketing of Virtual Real…

The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with...

Tulane University Study Uses AI to Detec…

A Tulane University researcher found that artificial intelligence (AI) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study...

Siemens Healthineers and UCSF Create Fir…

Siemens Healthineers and UC San Francisco have formed a research and innovation-driven collaboration to make radiological imaging greener, while improving access to and quality of radiological imaging in Northern California...

Open Call DIGITAL-2021-DEPLOY-01-HEALTH:…

The consolidation of a European framework and ecosystem of digital health solutions and services, covering technological and organisational innovation and addressing the needs of the involved stakeholders, including those of...

MEDICA 2021 + COMPAMED 2021: Holding the…

15 - 18 November 2021, Düsseldorf, Germany. This week, all of the big decision makers and professional experts from the international healthcare industry will finally be making their way to Düsseldorf...

MEDICA 2021 and COMPAMED 2021 have Far E…

15 - 18 November 2021, Düsseldorf, Germany. After their four-day run as an in-person event, MEDICA and COMPAMED have achieved extremely successful results in Düsseldorf. From 15 to 18 November 2021...

Philips Integrates MedChat's AI Capabili…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a collaboration with USA-based MedChat to integrate MedChat's live chat and AI-driven chatbot services into Philips Patient...